Let's continue on that path. When the allocation of $115 million for the Canadian Institutes of Health Research was announced, a portion of that went into developing test kits. In your submitted opening remarks, you talked about the point-of-care test kit. I understand there are three different methods of testing: the lab test, the point-of-care test and the serological test.
Can you expand on the point-of-care test kits and the advancement that's been made in that category specifically?